Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. (Q54647310)

2 June 2018

title

Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. (English)

1 reference

2 June 2018

author

Thorsten Schwark

3

1 reference

2 June 2018

Lee E. Eiden

10

1 reference

2 June 2018

Günter Klöppel

11

object named as

Günter Klöppel

1 reference

2 June 2018

author name string

Martin Anlauf

1

1 reference

2 June 2018

Martin K-H Schäfer

2

1 reference

2 June 2018

Nicole von Wurmb-Schwark

4

1 reference

2 June 2018

Viktoria Brand

5

1 reference

2 June 2018

Bence Sipos

6

1 reference

2 June 2018

Hans-Peter Horny

7

1 reference

2 June 2018

Reza Parwaresch

8

1 reference

2 June 2018

Wolfgang Hartschuh

9

1 reference

2 June 2018

Eberhard Weihe

12

1 reference

2 June 2018

publication date

22 August 2005

1 reference

2 June 2018

Journal of Histochemistry and Cytochemistry

published in

1 reference

2 June 2018

volume

54

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

201-213

1 reference

2 June 2018

Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes.

cites work

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Innervation of ectopic endometrium in a rat model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

The vesicular neurotransmitter transporters: current perspectives and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Functional identification and molecular cloning of a human brain vesicle monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Expression cloning of a reserpine-sensitive vesicular monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Molecular analysis of vesicular amine transporter function and targeting to secretory organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Liver findings in generalized mastocytosis. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Bone marrow findings in systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Spleen findings in generalized mastocytosis. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

In vivo radiotracers for vesicular neurotransmitter transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Histamine enhances TGF-beta1-mediated suppression of Th2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Mast cells and mast cell neoplasia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Transport mechanisms in acetylcholine and monoamine storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Vesicular neurotransmitter transporters: from bacteria to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Mediators of immediate hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Tryptase a novel biochemical marker of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

Chemical neuroanatomy of the vesicular amine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6739.2005

21 January 2018

Identifiers

DOI

10.1369/JHC.5A6739.2005

1 reference

2 June 2018

PubMed ID

16116033

1 reference

2 June 2018